Diagnostic biosensor
QuantuMDx’s novel nanowire based biosensor detects the binding of the regions of malaria DNA of interest to probes immobilized on the surface of the array of nanowires. This detection is based upon the DNA’s innate electrical charge which means there’s no fluorescence, no optics and no light.
The biosensor then converts the electrical signal straight into binary code, the universal language of computers. As we use standard CMOS produced computer chips, the Consortium is able to bring down the cost of complex malaria diagnostics into the low price point of routine pathology testing and, moreover, deliver this testing at the patient’s side.